GOLDMAN SACHS GROUP INC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 52 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q2 2022$2,300,0000.0%232,325
-0.4%
0.00%
Q1 2022$2,300,000
+0.2%
233,2250.0%0.00%
Q4 2021$2,295,000
+0.5%
233,225
-0.5%
0.00%
Q3 2021$2,283,000
+0.4%
234,419
-0.3%
0.00%
-100.0%
Q2 2021$2,273,000
+289.2%
235,019
+291.0%
0.00%
Q1 2021$584,00060,1040.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders